GC
SRDX

Guggenheim Capital’s Surmodics SRDX Stock Holding History

Guggenheim Capital’s Portfolio SRDX Stock Details SRDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-10,694
Closed -$318K – 1661
2025
Q2 		$318K Buy
10,694
+2,520
+31% +$72.6K ﹤0.01% 1378
2025
Q1 		$250K Sell
8,174
-3,020
-27% -$102K ﹤0.01% 1469
2024
Q4 		$443K Sell
11,194
-75
-0.7% -$2.92K ﹤0.01% 1316
2024
Q3 		$437K Hold
11,269
– – ﹤0.01% 1461
2024
Q2 		$474K Buy
+11,269
New +$384K ﹤0.01% 1455
2018
Q4 		– Sell
-8,452
Closed -$631K – 2355
2018
Q3 		$631K Buy
8,452
+1,589
+23% +$109K ﹤0.01% 1858
2018
Q2 		$378K Sell
6,863
-27,035
-80% -$1.25M ﹤0.01% 2099
2018
Q1 		$1.29M Buy
33,898
+245
+0.7% +$7.59K ﹤0.01% 1928
2017
Q4 		$941K Buy
33,653
+6,445
+24% +$197K ﹤0.01% 2110
2017
Q3 		$842K Buy
27,208
+1,742
+7% +$47.4K ﹤0.01% 2179
2017
Q2 		$715K Sell
25,466
-1,299
-5% -$31.4K ﹤0.01% 2262
2017
Q1 		$644K Sell
26,765
-3,010
-10% -$73.8K ﹤0.01% 2290
2016
Q4 		$756K Sell
29,775
-17,393
-37% -$457K ﹤0.01% 2268
2016
Q3 		$1.42M Sell
47,168
-6,576
-12% -$181K ﹤0.01% 1850
2016
Q2 		$1.26M Sell
53,744
-3,219
-6% -$70.5K ﹤0.01% 1878
2016
Q1 		$1.05M Sell
56,963
-11,230
-16% -$211K ﹤0.01% 2026
2015
Q4 		$1.38M Buy
+68,193
New +$1.45M ﹤0.01% 1894
2014
Q4 		– Sell
-22,798
Closed -$414K – 3095
2014
Q3 		$414K Sell
22,798
-2,404
-10% -$48K ﹤0.01% 2625
2014
Q2 		$540K Sell
25,202
-3,128
-11% -$67K ﹤0.01% 2569
2014
Q1 		$640K Sell
28,330
-11,711
-29% -$286K ﹤0.01% 2488
2013
Q4 		$977K Buy
+40,041
New +$944K ﹤0.01% 2254

Other funds holding SRDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OBAM
ODDO BHF Asset Management Paris, France $2.16B AUM 43.32% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $15.7B AUM 36.4% 1-Year Est. Return
RAM
Readystate Asset Management Chicago, Illinois $2.93B AUM 18.57% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Guggenheim Capital's SRDX Position: Q3 2025 in Review

Guggenheim Capital sold out of Surmodics (SRDX) in Q3 2025, closing a stake of 10,694 shares — an estimated $318K sold.

Guggenheim Capital first reported a position in SRDX in Q4 2013 and held it in 21 quarters. The position peaked at $1.42M in Q3 2016. 146 funds tracked by Wall St. Rank hold SRDX as of Q3 2025.

  • Guggenheim Capital reported no remaining Surmodics position as of Q3 2025 after selling out during the quarter.
  • Guggenheim Capital sold 10,694 Surmodics shares in Q3 2025, an estimated $318K.
  • Guggenheim Capital first reported a position in Surmodics in Q4 2013 and held it in 21 quarters.
  • Guggenheim Capital's Surmodics position peaked at $1.42M in Q3 2016.
  • 146 funds tracked by Wall St. Rank held Surmodics as of Q3 2025.

Based on Guggenheim Capital's 13F filing for Q3 2025, filed 13 Nov 2025.